Giulia Marvaso, Assistant Professor in the Department of Oncology and Hemato-Oncology at the University of Milan and Radiation Oncologist at IEO Milan, shared a post on X:
“Red pill or blue pill?
In the SBRT era, patients face real choices — radical vs targeted, invasive vs precise.
As Piet Ost presents QoL data from PACE A, shared decision-making isn’t just ideal, it’s essential.”
More posts featuring Giulia Marvaso.